Haixiang Qin

965 total citations
23 papers, 692 citations indexed

About

Haixiang Qin is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haixiang Qin has authored 23 papers receiving a total of 692 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Molecular Biology, 9 papers in Cancer Research and 8 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haixiang Qin's work include Bladder and Urothelial Cancer Treatments (3 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Haixiang Qin is often cited by papers focused on Bladder and Urothelial Cancer Treatments (3 papers), MicroRNA in disease regulation (3 papers) and RNA modifications and cancer (3 papers). Haixiang Qin collaborates with scholars based in China, United States and Italy. Haixiang Qin's co-authors include Hongqian Guo, Xiaozhi Zhao, Bo Jiang, Wenmin Cao, Qun Lu, Wei Chen, Minghui Liu, Limin Li, Rong Yang and Tianyao Liu and has published in prestigious journals such as Nature Communications, Chemosphere and Molecular Cancer.

In The Last Decade

Haixiang Qin

21 papers receiving 689 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Haixiang Qin China 13 477 419 144 77 43 23 692
Ying‐Chun Lin Taiwan 15 203 0.4× 115 0.3× 85 0.6× 81 1.1× 34 0.8× 33 615
Sunipa Majumdar United States 13 323 0.7× 115 0.3× 85 0.6× 107 1.4× 28 0.7× 20 521
Hong-Min Yan China 15 354 0.7× 132 0.3× 50 0.3× 85 1.1× 15 0.3× 43 808
Shufang Zhang China 16 481 1.0× 321 0.8× 178 1.2× 109 1.4× 10 0.2× 43 766
Jelena Milosevic United States 10 408 0.9× 162 0.4× 30 0.2× 109 1.4× 36 0.8× 20 602
Yunguang Li China 16 343 0.7× 148 0.4× 135 0.9× 164 2.1× 75 1.7× 34 821
Jer‐Yen Yang United States 13 501 1.1× 154 0.4× 53 0.4× 198 2.6× 34 0.8× 23 781
Haipeng Huang China 11 311 0.7× 133 0.3× 142 1.0× 119 1.5× 5 0.1× 32 534

Countries citing papers authored by Haixiang Qin

Since Specialization
Citations

This map shows the geographic impact of Haixiang Qin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haixiang Qin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haixiang Qin more than expected).

Fields of papers citing papers by Haixiang Qin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haixiang Qin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haixiang Qin. The network helps show where Haixiang Qin may publish in the future.

Co-authorship network of co-authors of Haixiang Qin

This figure shows the co-authorship network connecting the top 25 collaborators of Haixiang Qin. A scholar is included among the top collaborators of Haixiang Qin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haixiang Qin. Haixiang Qin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
3.
Yang, Yang, Wei Chen, Hongwei Shen, et al.. (2024). GALNT12 suppresses the bone-specific prostate cancer metastasis by activating BMP pathway via the O-glycosylation of BMPR1A. International Journal of Biological Sciences. 20(4). 1297–1313. 4 indexed citations
4.
Zhang, Zhijun, et al.. (2024). Velocity and Temperature Simulation for a Cylindrical Regenerative Thermal Oxidizer. ACS Omega. 9(14). 15893–15903. 2 indexed citations
5.
Jiang, Bo, Xiaozhi Zhao, Wei Chen, et al.. (2022). Lysosomal protein transmembrane 5 promotes lung-specific metastasis by regulating BMPR1A lysosomal degradation. Nature Communications. 13(1). 4141–4141. 27 indexed citations
6.
Ding, Meng, Xiaozhi Zhao, Wenli Diao, et al.. (2022). Cancer-associated fibroblasts promote the stemness and progression of renal cell carcinoma via exosomal miR-181d-5p. Cell Death Discovery. 8(1). 439–439. 25 indexed citations
7.
Yang, Yang, Haixiang Qin, Meng Ding, et al.. (2022). Small ankyrin 1 (sANK1) promotes docetaxel resistance in castration‐resistant prostate cancer cells by enhancing oxidative phosphorylation. FEBS Open Bio. 13(2). 257–269. 2 indexed citations
8.
Qin, Haixiang, Lei Yang, Mengxia Chen, et al.. (2022). circCYP24A1 promotes Docetaxel resistance in prostate Cancer by Upregulating ALDH1A3. Biomarker Research. 10(1). 48–48. 16 indexed citations
10.
Qin, Haixiang, Lin Du, Bo Jiang, et al.. (2022). Pan-cancer analysis identifies LMNB1 as a target to redress Th1/Th2 imbalance and enhance PARP inhibitor response in human cancers. Cancer Cell International. 22(1). 101–101. 15 indexed citations
11.
Pan, Chun, Haixiang Qin, Minghao Yan, et al.. (2022). Environmental microcystin exposure triggers the poor prognosis of prostate cancer: Evidence from case-control, animal, and in vitro studies. Journal of Environmental Sciences. 127. 69–81. 12 indexed citations
12.
Qin, Haixiang, Yang Yang, Bo Jiang, et al.. (2021). SOX9 in prostate cancer is upregulated by cancer‐associated fibroblasts to promote tumor progression through HGF/c‐Met‐FRA1 signaling. FEBS Journal. 288(18). 5406–5429. 20 indexed citations
13.
Qin, Haixiang, Bo Jiang, Wenfeng Lu, et al.. (2021). KLF2 inhibits cancer cell migration and invasion by regulating ferroptosis through GPX4 in clear cell renal cell carcinoma. Cancer Letters. 522. 1–13. 123 indexed citations
14.
Pan, Chun, Ling Zhang, Xiannan Meng, et al.. (2020). Chronic exposure to microcystin-LR increases the risk of prostate cancer and induces malignant transformation of human prostate epithelial cells. Chemosphere. 263. 128295–128295. 38 indexed citations
15.
Wang, Kaikai, Haixiang Qin, Xiaozhi Zhao, et al.. (2020). Internal cross-linked polymeric nanoparticles with dual sensitivity for combination therapy of muscle-invasive bladder cancer. Journal of Nanobiotechnology. 18(1). 124–124. 29 indexed citations
16.
Jiang, Bo, Wei Chen, Haixiang Qin, et al.. (2019). TOX3 inhibits cancer cell migration and invasion via transcriptional regulation of SNAI1 and SNAI2 in clear cell renal cell carcinoma. Cancer Letters. 449. 76–86. 19 indexed citations
17.
Lu, Qun, Tianyao Liu, Huijin Feng, et al.. (2019). Circular RNA circSLC8A1 acts as a sponge of miR-130b/miR-494 in suppressing bladder cancer progression via regulating PTEN. Molecular Cancer. 18(1). 111–111. 234 indexed citations
18.
Qin, Haixiang, Xuefeng Qiu, Linfeng Xu, et al.. (2019). Predictors for immediate recovery of continence following Retzius-sparing robot-assisted radical prostatectomy: a case–control study. International Urology and Nephrology. 51(5). 825–830. 10 indexed citations
19.
Gu, Yuanyuan, Shiwei Zhang, Gangqiang Li, et al.. (2019). Unbiased enrichment of urine exfoliated cells on nanostructured substrates for sensitive detection of urothelial tumor cells. Cancer Medicine. 9(1). 290–301. 8 indexed citations
20.
Zhang, Daning, Haixiang Qin, Ying Leng, et al.. (2018). LncRNA MEG3 overexpression inhibits the development of diabetic retinopathy by regulating TGF‑β1 and VEGF. Experimental and Therapeutic Medicine. 16(3). 2337–2342. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026